J Med Econ
September 2021
Aim: To evaluate the U.S. payer budget-impact of KidneyIntelX, an artificial intelligence-enabled diagnostic to predict kidney function decline in Type 2 Diabetic Kidney Disease (T2DKD) patients, stages 1-3b.
© LitMetric 2025. All rights reserved.